Dosage Forms & Drug Delivery Systems Research Group
The major aim of the Dosage Forms & Drug Delivery Systems Research Group (leader Assoc. Prof. PharmDr. Zdeňka Šklubalová, Ph.D.) is formulation of the conventional and modified-release dosage forms (DF). Special attention is paid to development and testing of micro- and nanoparticle carrier drug delivery systems (DDS), mainly for antineoplastic and nonsteroidal anti-inflammatory drugs. The group also deals with improvement solubility/bioavailability of BCS II/IV drugs using specific technological procedures such as liquisolid systems, self-emulsifying systems or co/milling with specific carriers.